Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 51: 215-217, 2005; 10.1373/clinchem.2004.039511
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakker, A. J.
Right arrow Articles by Zijlstra, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakker, A. J.
Right arrow Articles by Zijlstra, A.
Related Collections
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2005;51:215-217.)
© 2005 American Association for Clinical Chemistry, Inc.

Technical Briefs

Improved Reliability of Measurement of Lactate Dehydrogenase by IFCC Method in Heparin Plasma

Andries J. Bakkera, Anneke Bakker, Ageeth Bierma-Ram, Johannes T. Dijkstra, Hennie Renting-Wiering, Haye Syperda and Appie Zijlstra

Department of Clinical Chemistry, Klinisch Chemisch Laboratorium, PO Box 850, 8901 BR Leeuwarden, The Netherlands

aauthor for correspondence: fax 31-58-2882227, e-mail a.j.bakker@kcl.znb.nl

The first 20% of the full text of this article appears below.

Our laboratory recently reported (1) an excessively high frequency of duplicate errors in measurements of lactate dehydrogenase (LD; L-lactate:NAD+ oxidoreductase; EC 1.1.1.27) activity with the Roche IFCC-recommended method (2). This unacceptably high frequency of duplicate errors was found with various Hitachi analyzers (Roche GmbH) with primary lithium-heparin tubes with plasma separator from Becton Dickinson but not with serum or EDTA plasma. Such duplicate errors were not seen with the German- and French-recommended LD methods (3)(4), nor were such duplicate errors seen when nonevacuated heparin tubes from Sarstedt were used (5). In addition to the effects of methods, we investigated the effects of sample preparation, method modifications, mixing procedures, and the use of different lithium-heparin-containing tubes with and without plasma separator, lithium-heparin glass and plastic tubes, different lithium-heparin concentrations, and subsampling into secondary tubes. The results of all of these experiments are shown in Table 1 of the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem.org/content/vol51/issue1/.

Previously, we showed that the high frequency of duplicate errors was not caused by carryover from reagents for other tests and was not restricted to one specific type of Hitachi analyzer (1). In the present study, we demonstrate that the high frequency of duplicate errors is not restricted to the use of Roche reagents, confirming that the duplicate errors are caused by the combination . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Association for Clinical Chemistry.